Therapeutic options for patients with rare rheumatic diseases: a systematic review and meta-analysis

BACKGROUND: Rare diseases (RDs) in rheumatology as a group have a high prevalence, but randomized controlled trials are hampered by their heterogeneity and low individual prevalence. To survey the current evidence of pharmacotherapies for rare rheumatic diseases, we conducted a systematic review and...

Descripción completa

Detalles Bibliográficos
Autores principales: Bender, Tim T. A., Leyens, Judith, Sellin, Julia, Kravchenko, Dmitrij, Conrad, Rupert, Mücke, Martin, Seidel, Matthias F.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7603763/
https://www.ncbi.nlm.nih.gov/pubmed/33129321
http://dx.doi.org/10.1186/s13023-020-01576-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7603763/
https://www.ncbi.nlm.nih.gov/pubmed/33129321
http://dx.doi.org/10.1186/s13023-020-01576-5

Ejemplares similares